$17.99
arrow_drop_up1.92%Key Stats | |
---|---|
Open | $17.94 |
Prev. Close | $17.65 |
EPS | -5.48 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 17.43 | 18.15 |
52 Week Range | 17.43 | 34.87 |
Ratios | |
---|---|
EPS | -5.48 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk
Global Genetic Engineering Market Size To Worth USD 8.95 Billion By 2033 | CAGR Of 20.82%
Gene Editing Therapeutics Market Forecast 2024-2029: A $1 Billion Market by 2029, with a Forecasted CAGR of 147%
3 High-Risk Undervalued Stocks for Aggressive Investors Targeting 35%+ Upside
The Bull Case for Intellia Therapeutics Stock Just Got Even Stronger - The Motley Fool